Capricor Therapeutics is trading at $6.93, up +5.16%, with biotech-sector strength potentially supportive; no new company-specific announcement explaining the October 15 move was identified. - XBI is up 2.20% during the regular session. - The company’s latest listed release was October 5. - Recent clinical data and FDA review developments are prior news, not newly reported October 15 events.